Contralateral metachronous recurrence of ovarian mature teratoma following surgery in a child: a case report and literature review

In the landscape of childhood medicine, the ovaries are small but vital organs, responsible for producing hormones and, later in life, the potential for reproduction. Among the various growths that can appear there, a specific type known as a mature teratoma is one of the most common. These are benign tumors, meaning they are not cancer, and they are made up of tissues that the body normally produces, such as hair, skin, or fat. While they are generally harmless, they require removal because they can grow large enough to cause pain or twist the ovary. The standard approach for children is to carefully scoop out just the tumor while leaving the healthy ovarian tissue behind, a method designed to protect the child's future fertility. However, a lingering question has long puzzled doctors: if a child has one of these tumors removed, is it possible for a new, separate tumor to appear in the other ovary years later? This is not a case of the original tumor coming back, but rather a fresh growth arising on the opposite side, a phenomenon that demands a clear understanding of how long and how closely these young patients need to be watched.

A team of researchers at Suining Central Hospital recently brought this question into sharp focus by sharing the story of a ten-year-old girl and reviewing what is known about similar cases. The girl had previously undergone surgery to remove a mature teratoma from her left ovary. Four years after that successful operation, she returned with a fever and lower abdominal pain. During her initial surgery, doctors had found a tiny, barely noticeable spot on her right ovary two years after the first procedure, but because she felt fine at the time, she was not kept under close observation. By the time she returned with pain, that small spot had grown into a distinct mass measuring 2.3 centimeters. The medical team performed a second surgery, this time on the right side, and carefully removed the new tumor while preserving the healthy tissue. Pathology confirmed it was another mature teratoma, identical in nature to the first but located in the opposite ovary.

The significance of this case lies not in the rarity of the tumor itself, but in the timeline of its discovery and the lessons it offers for future care. The researchers noted that the second tumor was actually visible on an ultrasound scan two years after the first surgery, yet the lack of symptoms led to a break in monitoring. This gap allowed a small, silent lesion to grow into a symptomatic problem. The study highlights that these tumors can appear in the opposite ovary many years after the initial operation, and they often start as tiny, painless nodules that only a careful scan can detect. The authors point out that while some studies suggest these second tumors are rare, others indicate they could occur in up to one in five children, a wide range that suggests many cases might be missed if follow-up is not rigorous.

Through this specific case and a review of existing medical literature, the authors argue that the current approach of stopping checks once a child feels well is insufficient. They emphasize that because these tumors are benign and the surgery to remove them can be done with minimal damage to the ovary, the priority should be catching them early while they are still small. The paper suggests that children who have had one of these tumors removed should undergo annual ultrasound scans for at least ten years, or until they reach adulthood, to ensure that any new growth is spotted immediately. The goal is to maintain the health of the ovaries and the child's future ability to have children by intervening early, rather than waiting for pain or other signs to appear. The researchers conclude that while the exact frequency of these second tumors remains a subject of debate, the risk is real enough to warrant a long-term, disciplined plan of care for every child who undergoes this surgery.